Mediation between Bayer, plaintiffs seeks to clarify all justified claims: U.S. mediator

Mediation between Bayer, plaintiffs seeks to clarify all justified claims: U.S. mediator
FILE PHOTO: The logo of Bayer AG is pictured outside a plant of the German pharmaceutical and chemical maker in Wuppertal, Germany August 9, 2019. REUTERS/Wolfgang Rattay/File Photo BERLIN (Reuters) – Mediation between Bayer and plaintiffs in the United States aims to clarify all justified claims related to Roundup herbicide both at the national and state level, mediator Ken Feinberg... Read More

Biotech-for-hire PeptiDream charts new path and becomes short target

Biotech-for-hire PeptiDream charts new path and becomes short target
TOKYO (Reuters) – The promise of PeptiDream Inc’s drug-discovery technology and its lucrative research-for-hire contracts have made it a darling of the Tokyo stock market. Now, those gains have made it a target for short-seller Muddy Waters. Patrick Reid, President and CEO of PeptiDream Inc, poses for a photograph at the company headquarters in Kawasaki, Japan November 6, 2019. REUTERS/Rocky... Read More

U.S. company directors compensated more than ever, but now risk backlash

U.S. company directors compensated more than ever, but now risk backlash
BOSTON (Reuters) – It’s nice work if you can get it. FILE PHOTO: Microsoft founder Bill Gates smiles while playing bridge with Warren Buffett, CEO of Berkshire Hathaway Inc, as part of the company annual meeting weekend in Omaha, Nebraska U.S. May 6, 2018. REUTERS/Rick Wilking/File Photo The average annual compensation for non-executive directors at S&P 500 companies rose 2... Read More

T. Rowe Price’s McPherson sees green light for value stocks

T. Rowe Price’s McPherson sees green light for value stocks
NEW YORK (Reuters) – Economic uncertainty has held back value stocks, but fund manager Heather McPherson of T. Rowe Price Group Inc (TROW.O) sees plenty of opportunity to scoop up undervalued shares, including in the financial and utilities sectors. Heather McPherson, a co-portfolio manager and analyst at T. Rowe Price, speaks during a Reuters investment summit in New York City,... Read More

Teva Pharm says opioid settlement will not derail ability to cut debt

Teva Pharm says opioid settlement will not derail ability to cut debt
JERUSALEM/NEW YORK (Reuters) – Teva Pharmaceutical Industries Ltd (TEVA.TA) on Thursday expressed confidence in its ability to continue paying down its huge debt burden even if it is forced to pay billions of dollars to settle thousands of U.S. opioid lawsuits. FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference by its CEO, Kare Schultz,... Read More

Teva Pharm nudges up earnings forecast, names new CFO

Teva Pharm nudges up earnings forecast, names new CFO
JERUSALEM (Reuters) – Teva Pharmaceutical Industries (TEVA.TA) nudged up its full-year earnings guidance on Thursday, after reporting a drop in third-quarter profit that broadly met expectations. FILE PHOTO: The logo of Teva Pharmaceutical Industries is seen during a news conference by its CEO, Kare Schultz, to discuss the company’s 2019 outlooks in Tel Aviv, Israel February 19, 2019. REUTERS/Amir Cohen/File... Read More

Judge shields OxyContin-maker Purdue from litigation until April

Judge shields OxyContin-maker Purdue from litigation until April
(Reuters) – Purdue Pharma LP and the company’s Sackler family owners will be shielded until April 8, 2020, from sprawling opioid litigation to give the maker of OxyContin time to try to reach a legal settlement the company says is worth $10 billion. FILE PHOTO: Bottles of prescription painkiller OxyContin, 40mg, 20mg and 15mg pills, made by Purdue Pharma L.D.... Read More

Wall St. ends near flat; healthcare shares gain but trade deal delay weighs

Wall St. ends near flat; healthcare shares gain but trade deal delay weighs
NEW YORK (Reuters) – U.S. stocks ended little changed on Wednesday as a report the U.S.-China trade deal could be delayed until December was offset by gains in healthcare shares. The Nasdaq broke a three-day string of record closing highs, and the Dow barely snapped its two-day run of record highs. A senior official of the Trump administration told Reuters... Read More

Wall St little changed but report trade deal could be delayed weighs

Wall St little changed but report trade deal could be delayed weighs
NEW YORK (Reuters) – U.S. stocks were near flat on Wednesday as a report that the U.S.-China deal could be delayed until December increased worries about how long the trade war will go on, while healthcare shares supported the market. Traders work on the floor at the New York Stock Exchange (NYSE) in New York, U.S., November 6, 2019. REUTERS/Brendan... Read More

Pharmacy benefits, Aetna power CVS third-quarter profit beat

Pharmacy benefits, Aetna power CVS third-quarter profit beat
(Reuters) – CVS Health Corp (CVS.N) reported better-than-expected third-quarter profit and revenue on Wednesday, boosted by its Aetna health insurance and pharmacy benefits businesses, and it raised its 2019 earnings forecast. FILE PHOTO: People walk by a CVS Pharmacy store in the Manhattan borough of New York City, New York, U.S., November 30, 2017. REUTERS/Shannon Stapleton Shares of CVS, best... Read More